Search results
Alzheimer’s drug with modest benefits wins backing of FDA advisers
Nature· 5 days agoDonanemab slows progression of symptoms, but questions linger about the durability of its effect.
US ran secret anti-vax campaign to undermine China’s COVID efforts: Report
Al Jazeera· 4 hours agoAt the height of the COVID-19 pandemic, the United States military launched a secret campaign to...
Hybrid working has benefits over fully in-person working — the evidence mounts
Nature· 3 days agoSome employers are backing away from hybrid working, but research suggests that they need not be...
Far-right gains in European elections: what they mean for climate goals
Nature· 5 days agoA political shift to the right in Europe could make it harder to bring in more ambitious green...
Pentagon ran secret anti-vax campaign to incite fear of China vaccines
Reuters· 11 hours agoAt the height of the COVID-19 pandemic, the U.S. military launched a secret campaign to counter what...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
Digital Journal· 1 day agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age and olderHigher efficacy was observed in mRNA-1283 compared
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
The Kansas City Star· 1 day agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age and older
A surprising history of malaria is revealed by clues from ancient bones
KPBS San Diego· 1 day agoHow old is malaria? Researchers used to think it was two or three thousand years old at most — a...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Digital Journal· 4 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines in adults 50 years and older, including an ...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Morningstar· 4 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines in adults 50 years and older, including an ...